![]() |
|
|
Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706
2To whom correspondence should be addressed. E-mail: deluca{at}biochem.wisc.edu
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: fertility reproduction vitamin D receptor vitamin D and reproduction mice
| INTRODUCTION |
|---|
|
|
|---|
Vitamin D plays a role in calcium and phosphate homeostasis
(1)
. Previous reports have suggested that vitamin D also
is important in female reproduction of rats (2
,3)
.
However, female reproduction is not absolutely dependent on vitamin D
(4)
. Vitamin D did improve mating success and did increase
litter size. Vitamin D deficiency also impairs neonatal growth and
causes an increase in pregnancy complications. Vitamin D deficiency in
female rats led to an overall reduction in fertility of 75%. The
reduction resulted from a 50% decrease in mating efficiency and
complications during pregnancy. In addition, litter sizes of vitamin
D-deficient rats are 30% smaller than are those of vitamin
D-sufficient rats (2)
. In support of the idea
that vitamin D potentially plays a direct role in female reproduction,
the VDR has been found in the nuclei of reproductive tissues
(5)
and a hamster ovarian cell line (6)
.
The observed decrease in fertility has been postulated to result from
vitamin D deficiency rather than from the hypocalcemia associated with
vitamin D deficiency (3)
. Compared with vitamin
D-sufficient female rats, fertility in vitamin
D-deficient female rats was reduced by 67% (vitamin
D-deficient diet, hypocalcemic and normophosphatemic),
100% (vitamin D-deficient diet, normocalcemic and
hypophosphatemic), and 84% (vitamin D-deficient diet,
normocalcemic and normophosphatemic). Regardless of
Ca+2 and inorganic phosphate
(Pi) levels in the diet and, thus, the plasma,
vitamin D deficiency led to a reduction in fertility. Reproductive
capacity was restored in vitamin D-deficient rats within 3
wk by either D3 or
1,25(OH)2-D3
(3)
.
A new tool to investigate a possible role of vitamin D in reproduction
was recently provided by two groups in the development of VDR null
mutant mice (7
,8)
. Yoshizawa and colleagues
(8)
have reported that these female mice are unable to
reproduce and that the defect was presumably due to inadequate uterine
development. Dr. S. Kato kindly provided breeding stock of these mice
that allowed additional study. These VDR null mutant mice were
generated by a targeted disruption in exon 2, which includes the
transcriptional start site and the first Zn+2
finger of the VDR. The neomycin cassette insertion abolishes the
activity of vitamin D by eliminating the translation of a functional
VDR protein.
The VDR null mutant mice, after weaning, exhibit low serum calcium and
phosphate levels, alopecia and bone formation similar to vitamin
D-dependent rickets Type II in humans (8)
.
Infertility in the VDR null mutant mice has been investigated further
by studying the role of vitamin D in the regulation of estrogen
synthesis in the gonads, specifically aromatase enzyme activity and
expression in the ovaries, testes and epididymis (9)
. In
the null mutant mice, gene expression was low when compared with
wild-type mice and the aromatase activity was 24%, 58% and 35%
of the wild-type values in the ovary, testis and epididymis,
respectively. With dietary calcium supplementation (20% lactose),
there was an increase in aromatase activity in the ovary to 60% of
wild-type level. The authors conclude that estrogen biosynthesis is
regulated by calcium, but vitamin D may play an additional role
(9)
. However, the authors did not directly examine
fertility of these mice on the various diets.
The purpose of these experiments was to test whether the infertility in the VDR null mutant mice was a direct result of the nonfunctional VDR or a secondary result of the hypocalcemia. We now report that these VDR null mutant female mice are fully able to reproduce, despite a proven absence of a functional VDR; however, fertility in these mice is dependent on high dietary calcium levels.
| MATERIALS AND METHODS |
|---|
|
|
|---|
A modified nuclear extract of kidney and liver tissue was prepared as
described previously (10)
. A ligand-binding assay was
conducted on nuclear extracts based on a procedure of Wecksler and
Norman (11)
. Dilutions of the extract were incubated
overnight at 4°C with 2 nmol/L
1,25(OH)2-[3H]D3 [160 Ci/mmol
1,25(OH)2-D3] with and without 200 nmol/L
1,25(OH)2-D3. The next day, a 50% (v/v)
suspension of hydroxyapatite resin in 50 mmol/L of Tris-Cl (pH
7.4), 5 mmol/L of EDTA and 5 mmol/L of dithiothreitol was mixed with
the extract for 15 min. The resin was washed three times with TED +
0.5% Triton X-100. The washed collected resin was placed in a Biosafe
scintillation cocktail (Mount Prospect, IL) and counted in a Beckman
ß-counter (Palo Alto, CA). Protein concentration of nuclear extracts
was determined using a Bradford Assay (Bio-Rad, Hercules, CA) using
bovine serum albumin as the standard.
RNase protection assay.
Total RNA was isolated from mouse kidney and liver as described
previously (12)
. A polymerase chain reaction-generated
DNA fragment encoding the exon 2 of the rat VDR was cloned into
Bluescript vector (Stragene, La Jolla, CA). The Bluescript vector clone
was used to generate an RNA probe using a commercially available in
vitro transcription kit (Ambion, Austin, TX) and the probe was labeled
with [
32P] uridine triphosphate. An RNase protection
assay kit (Ambion) was used according to manufacturers instructions.
A 250-base pair mouse ß-actin probe was used as a control. Ten
micrograms or 30 µg of total RNA from VDR heterozygotes and null
mutant mice was hybridized with the exon 2/VDR probe or the ß-actin
probe. A 5% acrylamide · (8 mol/L urea) · (0.09 mol/L Tris borate,
0.002 mol/L EDTA) gel was run to separate the protected fragment. The
gel was dried and exposed to a phosphorimager screen for 18 h.
Animal maintenance.
A breeding colony was established from two pairs of mice (a generous
gift from Dr. Shigeaki Kato, Institute of Molecular and Cellular
Biosciences, University of Tokyo, Tokyo, Japan) that were heterozygous
for the VDR (8)
. The mice were housed in a 12-h light:12-h
dark cycle. They were maintained in cages with wooden shavings and
consumed distilled water and nonpurified or purified diet ab libitum.
All experimental protocols were received and approved by the Research
Animal Resources Center (University of Wisconsin-Madison, Madison,
WI).
Serum calcium analysis.
Blood was obtained by nicking the tail and serum was prepared by centrifugation. Serum was diluted 1:40 with 0.1 g/L of LaCl2 and calcium levels were determined using atomic absorption spectroscopy (Perkin-Elmer, Norfolk, CT).
Reproductive studies.
Wild-type and VDR ablated mice were fed one of four diets:
1) nonpurified diet (5015 Purina Chow, Richmond, IN)
containing 0.8% calcium, 0.5% phosphorus and 82.5 ng of vitamin D/g
of diet, 2) 10% lactose (13
,14)
, 100 g/kg
lactose, 1.2% calcium and 0.7% phosphorus diet supplemented with 75
ng of D3/g of diet, 3) high calcium diet,
1.2% calcium, 0.7% phosphorus diet supplemented with 75 ng of
D3/g of diet (in the absence of lactose) or
4) medium calcium diet, 0.8% calcium, 0.5% phosphorus
diet supplemented with 75 ng of D3/g of diet (in the
absence of lactose). In all cases, lactose was added at the expense of
the cerelose (glucose monohydrate) in the diet described by Suda et al.
(14)
. Serum calcium levels were monitored at breeding age
(7 wk). VDR null mutants and wild-type littermates were paired at 7
wk of age and allowed to mate. The time between potential mating and
parturition was monitored. The fertility frequency was followed for 3
mo. The number of pups produced was counted the morning after
parturition.
The effect of dietary calcium on fertility.
Both VDR ablated and wild-type mice were weaned onto the diet
described by Suda et al. (14)
that varied in calcium
percentages: 1) 0.02%, 2) 0.47%,
3) 0.87%, 4) 1.2% and 5)
2%. All experimental diets were supplemented with 75 ng of
D3/g of diet. Serum calcium levels were determined as
discussed in the serum calcium analysis section. At 78 wk of age, VDR
null mutants and wild-type mice were paired and allowed to mate.
The time between potential mating and parturition was monitored.
Statistical analysis.
SAS version 8 (SAS Institute, Cary, NC) was used to analyze statistical significance of the treatment groups. The data on serum calcium levels were analyzed using a mixed procedure (Proc GLM). A comparison of the least square means was used to determine significance between treatment groups. A Fishers exact test was used to analyze the significance of the fertility percentages. Differences with P < 0.05 value were considered significant.
| RESULTS |
|---|
|
|
|---|
Two lines of evidence were used to verify that the VDR was disrupted.
The absence or presence of a functional VDR protein was determined
using a ligand-binding assay (Fig. 1
; 11
). Kidney nuclear extracts of the null mutant mice
(89.8 ± 55.4 fmol/mg) had significantly reduced
1,25(OH)2-D3 binding
activity compared with extracts either from wild-type (573.9
± 6.77 fmol/mg) or heterozygous mice (414.2 ± 50.24
fmol/mg). Liver extracts, a vitamin D unresponsive tissue, were used as
a negative control in the ligand-binding assay for each genotype
(< 24 fmol/mg).
|
Fertility of the VDR null mutant mice.
The VDR null mutant mice have previously been reported to be infertile
(8)
. In contrast, VDR null mutants originally obtained
from Yoshizawa et al. (8)
reproduced in our laboratory as
efficiently as wild type but this ability depended on diet.
Interestingly, VDR null mutant mice, when maintained on a nonpurified
diet from weaning (21 d of age), were mostly infertile (14% fertile)
compared with wild-type mice with a 86% fertility (Table 1
). Both the VDR null mutant mice and wild-type mice were fertile
when fed the 10% lactose diet (100% fertility). Importantly, even in
the absence of lactose in the high calcium diet, the mice absent VDR
could reproduce as well as wild-type mice (100% fertility; Table 1
).
|
|
|
Litter size of VDR null mutant mice.
In vitamin D-deficient rats, the litter size is 30%
smaller than in vitamin D-sufficient rats
(2
,4)
. The average litter sizes for the VDR null mutant
mouse breeders consuming the lactose or high calcium diets were 4.2
± 1.10 pups and 3.5 ± 1.29 pups, respectively, which were
not significantly different from the litter sizes of wild-type
breeders fed 10% lactose or high calcium diets (3.9 ± 2.67 pups
and 5.29 ± 2.13 pups, respectively; both P > 0.1; Fig. 3
). Thus, a 30% decrease in litter size as occurred in litters from
vitamin D-deficient rats was not observed in the VDR null mutant
mice.
|
Initial experiments indicated that dietary calcium affected serum
calcium levels in the VDR null mutant mice (Table 2)
. Mice were then
fed diets differing in calcium concentration and their serum calcium
levels were monitored. VDR-ablated mice fed a diet containing
0.47% calcium had a significantly lower serum calcium level than
wild-type mice (P < 0.001). With higher dietary
calcium concentration (1.2% Ca+2 and 2%
Ca+2), VDR null mutant mice maintained serum
calcium levels similar to serum calcium levels in wild-type mice
(Table 3
; P > 0.1). VDR null mutant mice fed a diet deficient
in calcium (0.02% Ca+2) were extremely
hypocalcemic and they died at 67 wk of age (Table 3)
.
|
|
|
| DISCUSSION |
|---|
|
|
|---|
75% (2Dietary calcium levels had a marked effect on serum calcium concentrations of the VDR null mutant mice but not the wild-type mice. VDR-ablated mice that consumed a diet containing 0.47% calcium were hypocalcemic, and in these mice, reproduction efficiency was diminished by 30% compared with wild-type mice. VDR-ablated mice fed diets that could normalize serum calcium had 100% fertility, similar or higher than fertility percentage observed in wild-type mice. Thus, there seems to be a correlation between serum calcium levels and reproductive performance. Interestingly, VDR null mutant mice that did conceive in all cases had similar time length of mating and gestation as wild-type mice. Therefore, it seems that the defect in reproduction previously reported for these VDR null mutant mice is caused by hypocalcemia that resulted from the disruption of the function of vitamin D in calcium metabolism rather than the absence of the VDR itself.
Thus, in our hands, vitamin D null mutant mice do not fully illustrate the defect in female reproduction found with vitamin D-deficient rats. Vitamin D-deficient rats apparently have a 75% decrease in fertility because of a 50% decrease in mating efficiency and an overall increase in pregnancy complications. Based on these results, it was indeed unexpected that VDR null mutant mice were found capable of reproduction. Therefore, this represents a major departure in the two models to study the role of vitamin D in this function. The decrease in fertility due to deficiency of vitamin D was found in rats, whereas the present studies were carried out in mice. It is possible that an important species difference and it is indeed possible that vitamin D-deficient female mice will be fully capable of reproduction. In contrast, it is possible that vitamin D could have a function in female reproduction that is not mediated by the VDR. Still another possibility is that another, yet unknown, VDR functions in reproduction. These different possibilities warrant additional investigation but, at the present time, it is unknown why there is a discrepancy between the vitamin D-deficiency studies in rats and the current studies in the VDR null mutant mice.
| FOOTNOTES |
|---|
3 Abbreviations used: VDR, vitamin D
receptor; 1,25(OH)2-D3,
1,25-dihydroxycholecalciferol; D3, cholecalciferol;
RXR, retinoid X receptor; Pi, inorganic phosphate. ![]()
Manuscript received December 18, 2000. Initial review completed January 24, 2001. Revision accepted March 23, 2001.
| REFERENCES |
|---|
|
|
|---|
1.
Jones G., Strugnell S. A., DeLuca H. F. Current understanding of the molecular actions of vitamin D. Physiol. Rev. 1998;78:1193-1231
2. Halloran B., DeLuca H. F Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J. Nutr. 1980;110:1573-1580
3.
Kwiecinski G. G., Petrie G. I., DeLuca H. F. 1,25-Dihydroxyvitamin D3 restores fertility of vitamin D-deficient female rats. Am. J. Physiol. 1989;256:E483-E487
4.
Halloran B., DeLuca H. F. Vitamin D deficiency and reproduction in rats. Science 1979;204:73-74
5. Stumpf W. E., Denny M. E. Vitamin D (soltriol), light, and reproduction. Am. J. Obstet. Gynecol. 1989;161:1375-1384[Medline]
6.
Dokoh S., Donaldson C. A., Marion S. L., Pike J. W., Haussler M. R. The ovary: a target organ for 1,25-dihydroxyvitamin D3. Endocrinology 1983;112:200-206
7.
Li Y. C., Pirro A. E., Amling M., Delling G., Baron R., Bronson R., Demay M. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997;94:9831-9835
8. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia, and growth retardation after weaning. Nat. Genet. 1997;16:391-396[Medline]
9.
Kinuta K., Tanaka H., Moriwake T., Aya K., Kato S., Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 2000;141:1317-1324
10.
Pierce E. A., Dame M. C., DeLuca H. F. Size and charge of the functional 1,25-dihydroxyvitamin D receptor in porcine intestine. J. Biol. Chem. 1987;262:17092-17099
11.
Wecksler W. R., Norman A. W. An hydroxylapatite batch assay for the quantitation of 1
,25-dihydroxyvitamin
D3-receptor complexes. Anal. Biochem. 1979;92:314-323[Medline]
12. Auffray C., Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 1980;107:303-314[Medline]
13. Dupuis Y., Fournier P. Lactose and the absorption of calcium and strontium. Wasserman H. R. eds. The Transfer of Calcium and Strontium across Biological Membranes 1962:277-293 Academic Press New York, NY
14. Suda T., DeLuca H. F., Tanaka Y. Biological activity of 25-hydroergocalciferol in rats. J. Nutr. 1970;100:1049-1052
This article has been cited by other articles:
![]() |
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.E. Chavarro, J.W. Rich-Edwards, B. Rosner, and W.C. Willett A prospective study of dairy foods intake and anovulatory infertility Hum. Reprod., May 1, 2007; 22(5): 1340 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Du, G. S. Daftary, S. I. Lalwani, and H. S. Taylor Direct Regulation of HOXA10 by 1,25-(OH)2D3 in Human Myelomonocytic Cells and Human Endometrial Stromal Cells Mol. Endocrinol., September 1, 2005; 19(9): 2222 - 2233. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kovacs, M. L. Woodland, N. J. Fudge, and J. K. Friel The vitamin D receptor is not required for fetal mineral homeostasis or for the regulation of placental calcium transfer in mice Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E133 - E144. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakagawa, A. Kawaura, S. Kato, E. Takeda, and T. Okano 1{alpha},25-Dihydroxyvitamin D3 is a preventive factor in the metastasis of lung cancer Carcinogenesis, February 1, 2005; 26(2): 429 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. N. Evans, J. N. Bulmer, M. D. Kilby, and M. Hewison Vitamin D and Placental-Decidual Function Reproductive Sciences, July 1, 2004; 11(5): 263 - 271. [Abstract] [PDF] |
||||
![]() |
D. K. Panda, D. Miao, I. Bolivar, J. Li, R. Huo, G. N. Hendy, and D. Goltzman Inactivation of the 25-Hydroxyvitamin D 1{alpha}-Hydroxylase and Vitamin D Receptor Demonstrates Independent and Interdependent Effects of Calcium and Vitamin D on Skeletal and Mineral Homeostasis J. Biol. Chem., April 16, 2004; 279(16): 16754 - 16766. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Miao, B. He, B. Lanske, X.-Y. Bai, X.-K. Tong, G. N. Hendy, D. Goltzman, and A. C. Karaplis Skeletal Abnormalities in Pth-Null Mice Are Influenced by Dietary Calcium Endocrinology, April 1, 2004; 145(4): 2046 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Demay Muscle: A Nontraditional 1,25-Dihydroxyvitamin D Target Tissue Exhibiting Classic Hormone-Dependent Vitamin D Receptor Actions Endocrinology, December 1, 2003; 144(12): 5135 - 5137. [Full Text] [PDF] |
||||
![]() |
J. Welsh, J. A. Wietzke, G. M. Zinser, B. Byrne, K. Smith, and C. J. Narvaez Vitamin D-3 Receptor as a Target for Breast Cancer Prevention J. Nutr., July 1, 2003; 133(7): 2425S - 2433. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. M. Sutton and P. N. MacDonald Vitamin D: More Than a "Bone-a-Fide" Hormone Mol. Endocrinol., May 1, 2003; 17(5): 777 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Johnson and H. F. DeLuca Reproductive Defects Are Corrected in Vitamin D-Deficient Female Rats Fed a High Calcium, Phosphorus and Lactose Diet J. Nutr., August 1, 2002; 132(8): 2270 - 2273. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Erben, D. W. Soegiarto, K. Weber, U. Zeitz, M. Lieberherr, R. Gniadecki, G. Moller, J. Adamski, and R. Balling Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D Mol. Endocrinol., July 1, 2002; 16(7): 1524 - 1537. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zehnder, K. N. Evans, M. D. Kilby, J. N. Bulmer, B. A. Innes, P. M. Stewart, and M. Hewison The Ontogeny of 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Expression in Human Placenta and Decidua Am. J. Pathol., July 1, 2002; 161(1): 105 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zinser, K. Packman, and J. Welsh Vitamin D3 receptor ablation alters mammary gland morphogenesis Development, January 7, 2002; 129(13): 3067 - 3076. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||